期刊文献+

有机合成在创新药物研发中的应用与进展 被引量:15

Application and Progress of Organic Synthesis in the Discovery of Innovative Drugs
原文传递
导出
摘要 论述了现代有机合成化学在一些创新药物尤其是"重磅炸弹"新药,如索非布韦(Sofosbuvir)、利伐沙班(Rivaroxaban)、恩杂鲁胺(Enzalutamide)、卡格列净(Canagliflozin)和托法替尼(Tofacitinib),研发中的应用和进展,突出显示了催化过程、闭环复分解反应、钯催化的交叉偶联、绿色化学和叠缩工艺等合成方法.通过数十个新分子实体药物发明历程的回顾,诠释了现代有机合成在新药开发中的重要作用. This article reviews the application and progress of modern synthetic methods to deliver several innovative drugs, especially the blockbusters, such as sofosbuvir, rivaroxaban, enzalutamide, canagliflozin and tofacitinib. Some of the modern synthetic methods, for example catalytic processes, application of ring-closing metathesis, palladium catalyzed cross-coupling, green chemistry and telescoping of processes, are highlighted. The exciting journey from discovering these new molecular entities, especially those which are first-in-class with the synthesis of a dozen of approved drugs, is described as case studies to fully illustrate the important role of modern organic synthesis for successful drug discovery and development.
出处 《有机化学》 SCIE CAS CSCD 北大核心 2015年第2期337-361,共25页 Chinese Journal of Organic Chemistry
基金 广东省引进创新创业团队计划(No.201301Y0105381261)资助项目~~
关键词 药物 药物合成 有机合成 合成艺术 drugs drug synthesis organic synthesis art in drug synthesis
  • 相关文献

参考文献5

二级参考文献57

共引文献87

同被引文献73

  • 1杨金丽,刘娥.有机合成对药物研发的创新应用及发展[J].包装世界,2018,0(9):101-102. 被引量:1
  • 2宋丽君,王飏,陆旭芳,李志裕.雄激素受体拮抗剂MDV3100的合成研究[J].精细化工中间体,2012,42(1):34-36. 被引量:7
  • 3焦克芳,袁越,李松.21世纪药物化学展望[J].国外医学(药学分册),1994,21(6):321-325. 被引量:13
  • 4崔福德.药剂学[M].北京:人民卫生出版社,2008:311-314.
  • 5TRAN C,OUK S,CLEGG N,et al. Development of a second generation antiandrogen for treatment of ad- vanced prostate cancer [J]. Science,2009,324(5928).. 787-790.
  • 6CHARLES kS,MICHAEL EJ,CHARLIE DC,et al. Di- arylhydantoin Compounds: US, 7709517 [ P ].2010-05-04.
  • 7HOWARD L SCHER,KARIM FIZAZI,FRED SAAD, et al. Increased survival with enzalutamide in prostate af- ter chemotherapy[OL]. N Engl Med: 2012-8-15.
  • 8FOSSA SD, SLEE PH, Brausi M, et al. Flutamide versus prednisone in patients with prostate cancer symptomati- cally progressing after androgen-ablative therapy: a phase III study of the European organization for re- search and treatment of cancer genitourinary group [J]. J Clin Oncol,2001,19(1 ) :62-71.
  • 9AKAZA H,HINOTSU S,USAMI M,et al. Study group for the combined androgen blockade therapy of prostate cancer combined androgen blockade with hiealutamide for advanced prostate cancer: long-term follow-up of a phase 3,double-blind,randomized study for survival [ J ]. Cancer, 2009 ; 115 ( 15 ) : 3437-3445.
  • 10CRAWFORI) E D,EISENBERGER M A,MCLEOD DG,et al. A controlled trial of leuprolide with and with- out flutamide in prostatic carcinoma[J]. N Engl J Med, 1989,321 (7) :419-424.

引证文献15

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部